Blog - Page 1506 of 5718

ThursdayFeb 18, 2021 11:04 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Update Regarding Informal Acquisition Inquiry, Development of MOU for Potential Joint Venture

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today updated its recent announcement that it has been approached by a Canadian cannabis company to enter into discussions concerning a potential acquisition transaction. The discussions have evolved to include development of a memorandum of understanding (“MOU”) that sets forth terms under which the parties could enter into a joint venture to jointly manufacture, distribute and market Grapefruit’s products. These include, but are not limited to, Grapefruit’s patented disruptive Hourglass(TM) THC/Cannabinoid time-release delivery cream throughout Canada. “As previously announced, Grapefruit is not surprised that we have been approached concerning…

ThursdayFeb 18, 2021 10:15 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Signs Distribution Agreement with Canada House Wellness Group

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has signed an agreement with Canada House Wellness Group (CSE: CHV) to distribute concentrate products through existing provincial distribution channels. Canada House Wellness is a fully integrated medical cannabis company. The two companies have entered into a Cannabis 2.0 distribution agreement. The agreement notes that Canada House's wholly owned subsidiary Abba Medix Corp. will carry and distribute Pure Extracts' line of concentrate products. Canada House’s leadership team noted that it was impressed with the Pure…

ThursdayFeb 18, 2021 10:00 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Large Cannabis Biomass Agreements to Scale Up Extract Production, Announces DTC Eligibility of Common Shares in the U.S.

Pure Extracts entered into two large biomass purchase agreements, plans to ramp up production of high-potency THC and CBD extracts in 2021 Company expects historically low biomass purchase price will produce $590,000 revenue Company recently announced DTC eligibility of common shares for increased settlement and clearance speeds, wider access to brokerage firms Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company that focuses on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelics sector, recently entered into two substantial cannabis biomass purchase agreements (https://ibn.fm/Vbyxp) in addition to announcing that its common shares are now eligible for…

ThursdayFeb 18, 2021 9:48 am

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTC: IMEXF) Announces Closing of 2nd Tranche of Convertible Note Offering

Imagin Medical (CSE: IME) (OTC: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced that, further to its press releases of Oct. 22 and Nov. 10, 2020, it has closed the second tranche in the amount of US$1,415,500 of the convertible note offering. According to the update, a total convertible note amount of $2,165,500 has been raised to date. All securities issued in connection with the offering will be subject to a four-month statutory hold period plus one day from the date of issuance in accordance with…

ThursdayFeb 18, 2021 9:40 am

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Improving the Odds in Fighting Bladder Cancers

Imagin Medical Inc. is a surgical imaging company helping to advance the use of blue light cystoscopy (“BLC”) in battling bladder cancer and reducing costs associated with these procedures Bladder cancer is the sixth most prevalent cancer in the United States, and the third most common in men, yet the most expensive to treat While early-stage cancer intervention involves illuminating the bladder with white light – the light that can be seen by the human eye - to visualize and resect tumors, historical use of white light has resulted in incomplete tumor removal and a greater than 50% recurrence rate…

ThursdayFeb 18, 2021 9:20 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation of Medicines with Potential to Treat Rising Mental Health Challenges from Depression

Mental health experts note growing concern over impact of COVID-19 on nation’s mental health Compounding stress could have serious health, social consequences VTGN offers new hope to those dealing with depression disorders A new survey from the American Psychological Association (“APA”) shines a spotlight on the growing concern about the impact of the global pandemic on the nation’s mental health (https://ibn.fm/ukaIx). These rising numbers, as well as the treatment for mental health illness and disorders, is of great concern to VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medications that goes beyond the standard of…

ThursdayFeb 18, 2021 9:20 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) to File Restated Financial Statements, MD&A

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that, after review, it will refile its condensed interim consolidated financial statements and management's discussion & analysis ("MD&A") for the three- and six-month periods ended March 31, 2020. In earlier versions of the MD&A, Champignon had recognized intangible assets that had resulted from the acquisitions of Artisan Growers Ltd., Novo Formulations Ltd. and Tassili Life Sciences Corp.; those assets totaled an estimated $12 million. Following the issuance of the original MD&A and other financial statements, it was determined that some information contained in the financial statements needed to be restated, specifically as…

WednesdayFeb 17, 2021 2:41 pm

Friendable Inc. (FDBL) Positioned to Capitalize Live Streaming Growth Opportunities Through Fan Pass Platform

Businessman and musician Armando Christian Perez or “Pitbull” discussed the need for the music industry to continue on the path of live streaming concert availability Revenue in the global music streaming industry is expected to total $23,053 million in 2021, with the United States contributing the most at $8,669 million Friendable Inc. saw a 354% increase in artist sign-ups from December 2020 to January 2021, totaling 1,072 and counting since launching the Fan Pass platform in July 2020 The average online pay-per-view concert ticket is $27, providing artists with a venue with unlimited seats. The average in-person concert ticket price…

WednesdayFeb 17, 2021 2:20 pm

HYB Holding Corp. (HYBG) and Mediscan Subsidiary Look to Make Significant Impact in Global Medical Imaging Market

Global billion-dollar market projected to see steady growth in coming years Technological advancements expected to contribute to market growth Mediscan software transforms traditional 2D grayscale images into digital 3D high-definition images readily accessible to healthcare providers. The United States medical imaging market size in 2020 valued at US$134 billion (https://ibn.fm/1oQo2), HYB Holding (OTC: HYBG) is looking to its two-month-old acquisition, Mediscan Inc., to bring significant value to the table. Acquired in November 2020 through a reverse acquisition transaction, Mediscan is a cloud-based software technology used in ultrasound that reconstructs the traditional analog two-dimensional (2D) grayscale visual image into a digital three-dimensional (3D),…

WednesdayFeb 17, 2021 2:06 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Leverages Genetics to Produce Potent CBD Strains Amid New Research Suggesting CBD Aids COVID-19 Patients

Austrian researchers report CBD reduces inflammation and speeds recovery in ICU COVID-19 patients Research suggests CBD’s anti-inflammatory properties stave off long-term neurological damage associated with COVID-19 PACR leverages genetic technology to produce potent CBD strains with higher yields per growing season Company catalog includes 350 cultivars and 50 super-elite strains prized in industry CBD may soon become the newest support in the world’s fight against COVID-19: Researchers at the Klagenfurt Clinic in Austria recently reported positive results from cannabidiol (“CBD”) trials on COVID-19 patients that demonstrated reduced inflammation and quicker recovery times (https://ibn.fm/vhsIS). Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF), a…

Site Search

Company Search